Ayesh, S <br/><br/>
Reversal of P-glycoprotein is greatly reduced by the presence of plasma but can be monitored by an ex vivo clinical assay.  [electronic resource] 

 -  Anti-cancer drugs  Aug 1996 
 - 678-86 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. 
<br/><br/><label>ISSN: </label>0959-4973 
<br/><br/><label>Standard No.: </label>10.1097/00001813-199608000-00009  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>ATP Binding Cassette Transporter, Subfamily B, Member 1--antagonists & inhibitors<br/>Animals<br/>Cyclosporine--blood<br/>Daunorubicin--metabolism<br/>Drug Screening Assays, Antitumor<br/>Humans<br/>Kidney--metabolism<br/>Leukemia P388--drug therapy<br/>Mice<br/>Plasma<br/>Quinidine--blood<br/>Verapamil--pharmacology<br/>Vinblastine--metabolism